ABSTRACT Folate turnover involves urinary excretion, fecal excretion, and catabolism that involves cleavage of the C9-N10 bond to yield pterins and para-aminobenzoylglutamate (pABG). Little is known about the relationship between the function of folate pools and their rates of catabolism. We report here an investigation of excretion of urinary pABG and its primary excretory form, para-acetamidobenzoylglutamate ( 
The role of a catabolic process in folate metabolism has long been recognized. Dinning et al. (1957) first reported the excretion of free and acetylated diazotizable amines after administration of folic acid or 5-formyltetrahydrofolate in rats. Subsequent studies indicated that the catabolic process involved cleavage of the folate C9-N10 bond, with the primary excretory products identified as various pterins (Krumdieck et al. 1978) , and the folate-derived amines including para-aminobenzoylglutamate (pABG) and its N-acetyl derivative, paraacetamidobenzoylglutamate (ApABG) (Barford et al. 1978 , Murphy et al. 1976 , Murphy and Scott 1979 . The urinary excretion of ApABG greatly exceeds that of nonacetylated pABG (Caudill et al. 1998 , Geoghegan et al. 1995 , McNulty et al. 1987 , McPartlin et al. 1992 ). Acetylation appears to be catalyzed by an arylamine N-transferase isoform with specificity toward pABG (Estrada-Rodgers et al. 1998 , Minchin 1995 .
The relationship between folate nutritional status and the rate of pABG and ApABG excretion has not been fully established, although excretion of pABG and/or ApABG is not clearly indicative of folate nutritional status. In addition, it is unclear which specific form(s) of folate and body pools are most prone to catabolism. Urinary excretion of folate catabolites greatly exceeds the excretion of intact folate in rats (Wang et al.1994 ) and humans (Caudill et al. 1998 . At higher intakes of folate, urinary folate excretion increases to a proportionally greater extent than does catabolite excretion. Supplementation with folic acid has little effect on the short-term excretion of folate catabolites (Kownacki-Brown et al. 1993 , McNulty et al. 1987 . In studies of chronic control of folate intake, the excretion of folate catabolites is proportional to folate intake (Caudill et al. 1998 ). In a study in which nonpregnant women were chronically given oral doses of deuterated folic acid, examination of the rate and extent of labeling of ApABG provided evidence that folates from both rapid-and slowturnover pools are subject to catabolism . For all intakes examined (200, 300 and 400 g total folate/d), ApABG excretion greatly exceeded the excretion of intact folate. The sum of pABG and ApABG, along with concurrently formed pterins, appears to account for the majority of folate catabolites. Geoghegan et al. (1995) concluded that the excretion of ApABG is itself a suitable indicator of folate catabolism. Folate catabolism also may be increased by anticonvulsant drugs, alcohol and certain cancers (Kelly et al. 1979 and 1981 , Shaw et al. 1989 .
Measurement of total excretion of folate catabolites (i.e., ApABG ϩ pABG) has been reported in a number of studies. 2 Reference to a company or product name does not imply approval or recommendation of the product by the U.S. Department of Agriculture to the exclusion of others that may be suitable. 3 To whom correspondence should be addressed.
0022-3166/00 $3.00 © 2000 American Society for Nutritional Sciences. McPartlin et al. (1993) examined catabolite excretion in free-living pregnant women and nonpregnant controls. They reported that nonpregnant controls, postpartum women and women in the first trimester of pregnancy excreted total catabolites that were the equivalent of ϳ100 g of folate/d, which corresponded to ϳ227 nmol/d. Greater excretion of catabolites was reported during the second and third trimesters of pregnancy. Long-term dietary control was not employed in that study. Caudill et al. (1998) conducted a similar study except that folate intake was precisely controlled for 12 wk in second trimester pregnant women and nonpregnant controls. In this protocol, no difference was observed between pregnant and nonpregnant women consuming the same level of folate (either 450 or 850 g/d). However, the steady-state excretion of total pABG ϩ ApABG increased in proportion to folate intake. The study of Caudill et al. (1998) showed clearly that at least 4 wk was required during these relatively high levels of controlled intake. Little is known about the level of folate catabolism and time required for catabolite excretion to stabilize during periods of low dietary folate intake. In this paper, we report the measurement and interpretation of pABG and ApABG excretion in a study with carefully controlled dietary intake intended to provide depletion followed by repletion with folate. This provided an ideal context for examination of effects of a modest folate deficiency on catabolite excretion. Detailed analysis of the influence of dietary intake on various functional indices of folate status has been reported in a separate publication (Jacob et al. 1998 ).
SUBJECTS AND METHODS

Protocol.
As described previously (Jacob et al. 1998) , healthy nonsmoking postmenopausal volunteer women (n ϭ 10), ages 49 -63 y, were admitted to the metabolic unit of the USDA Western Human Nutrition Research Center (WHNRC) after medical and psychological screening. Normal renal function was ensured by testing for serum creatinine, blood urea nitrogen and urinalysis at screening and biweekly throughout the study. Tests for plasma folate and vitamin B-12, alcohol, tobacco and drug use were also performed. All subjects were within 90 -130% of desirable weight (Metropolitan Life Insurance Company, New York, NY), except for one subject who was 145% of desirable weight. Other criteria for subject selection included the following: nonsmokers, nonusers of vitamin or other dietary supplements containing folic acid, hemoglobin Ͼ 115 g/L and hematocrit Ͼ 0.34. Three subjects, who were receiving estrogen replacement therapy when they entered the study, continued the same regimen throughout. The study protocol and informed consent were approved by the Human Subjects Review Committee of the University of California, Davis, and by the Human Studies Review Committee of the Agricultural Research Service, U. S. Department of Agriculture. Signed informed consent was obtained from each volunteer. For the duration of the 91-d study, the subjects lived in and ate all meals in the WHNRC metabolic unit and were chaperoned at all times when outside the unit.
Throughout the 91-d study, a low folate, low choline diet was fed, which provided an average of 56 g/d folate from food sources (Jacob et al. 1999) . Synthetic folic acid (pteroylglutamic acid) was added to the diet at various stages of the protocol to allow precise control of folate intake from 56 to 516 g/d. Total folate intakes were as follows:
Specimen collections and analytical methods. Blood samples were obtained weekly, and complete urine collections were obtained as successive 7-d pools for each subject. All samples were stored at Ϫ70°C until analyzed. Urinary pABG and ApABG were measured using the procedure of McPartlin et al. (1992) with modifications as described by Caudill et al. (1998) . Excretion per day of pABG and ApABG was calculated by multiplying the concentration of each compound in a given pooled urine sample by the mean daily urine volume. We analyzed four urine pools corresponding to study d 1-7 (baseline), 36 -42, 64 -70 and 85-91 Additional measurements reported here were made using methods described in the previous paper regarding this study (Jacob et al. 1998) , including the following. Plasma homocysteine was measured by fluorometric HPLC (Araki and Sako 1987) . The methyl acceptance capacity of lymphocyte DNA was measured by a modification of the method of Balaghi and Wagner (1993) Statistical analysis. The effects of folate intake on the excretion of each catabolite in the respective dietary treatment periods were determined by one-way repeated-measures ANOVA (Glantz 1992) . Further analysis of data, including molar ratios of ApABG/(pABG ϩ ApABG) and (pABG ϩ ApABG)/total folate intake, was also conducted by one-way repeated-measures ANOVA. Differences were considered significant at P Ͻ 0.05. When significance was observed, multiple comparisons were conducted using the Student-NewmanKeuls method. Statistical analyses were conducted using SigmaStat for Windows version 1.0 (Jandel Corporation, San Rafael, CA).
RESULTS
The measurement of urinary folate catabolites yielded the results presented in Table 1 . Excretions of pABG and ApABG did not change significantly during the experiment. Summarizing observations for all samples collected throughout this protocol, the subjects excreted 308 Ϯ 27.5 nmol ApABG/d and 25.3 Ϯ 2.48 nmol pABG/d (means Ϯ SEM, n ϭ 40 total observations). Total folate catabolite excretion (i.e., pABG ϩ ApABG) was 333 Ϯ 28.4 nmol/d (mean Ϯ SEM, n ϭ 40 total observations), which corresponds to daily elimination of 147 Ϯ 12.5 g folic acid equivalents through catabolism throughout this study. The excretion of ApABG constituted 89.9 Ϯ 1.50% of total pABG ϩ ApABG excretion (mean Ϯ SEM, n ϭ 40 total observations), and this value did not change significantly throughout the various dietary periods of the study.
We also investigated the relationship between excretion and folate intake. The molar ratio of total urinary pABG ϩ ApABG/folate intake varied markedly (P Ͻ 0.0001) over the course of the study (Table 1) . This molar ratio rose from 1.05 Ϯ 0.17 during the initial dietary period (155 g/d folate intake) to 3.0 Ϯ 0.55 during the 58 g/d depletion period (means Ϯ SEM, P Ͻ 0.0001). In other words, folate catabolite excretion exceeded folate intake by a factor of ϳ3 during wk 5 of 58 g/d folate intake.
DISCUSSION
Although the very substantial role of folate catabolism as a component of folate turnover has been demonstrated previously, little is known about the body folate pool(s) that undergo(es) catabolism. Jacob et al. (1998) reported data from this study indicating that plasma homocysteine and methylation status of lymphocyte DNA underwent significant changes during the course of the dietary manipulations of this protocol. These findings contrast with the observations reported here, indicating that folate catabolism is only weakly influenced by short-term changes of folate intake. Thus, we infer that folate pools that serve as precursors of folate catabolites differ from those directly involved in cellular acquisition and generation of onecarbon units, as 5-methyl-tetrahydrofolate, destined for homocysteine remethylation and formation of S-adenosylmethionine for cellular methylation reactions. The results of this study are consistent with the findings of Caudill et al. (1998) who reported that the excretion of folate catabolites increased slowly after the initiation of folate supplementation in pregnant women and nonpregnant controls.
The calculation of the molar ratio of catabolites and folate intake is not meant to imply that there is a direct temporal linkage between recently ingested folate and excreted catabolites. By contrast, the molar ratio of ϳ3 after 5 wk of 58 g/d folate intake demonstrates clearly that it was the tissue folate derived from previous intake that yielded the excreted catabolites. This is consistent with the observation of KownackiBrown et al. (1993) , who found that only a small percentage of a bolus oral dose of deuterated folate appeared in short-term collections of urine. Under the conditions of this protocol, it is likely that the overall turnover of body folate would occur very slowly, probably with an overall mean residence time for total body folate of ϳ200 d as reported by Gregory et al. (1998) . This is consistent with the lack of significant change in red cell folate, which is known to turn over much more slowly than the 5-methyl-tetrahydrofolate pool. The relatively rapid responsiveness of plasma homocysteine, and lymphocyte DNA methylation status reported by Jacob et al. (1998) suggests that 5-methyl-tetrahydrofolates responsible for these functional changes of one-carbon metabolism are in a much greater state of flux than the bulk of the body folate pools, which turn over much more slowly. Several abundant enzymes are known to bind folate very tightly, which may account for a portion of the large, relatively refractory component of body folate. Further work is required to identify such pools and their in vivo behavior. An additional finding of interest is the fact that the proportion of total pABG that undergoes acetylation of the aryl amino group is relatively constant and not influenced by the level of folate intake. It should be noted that the diet used in this study was low in choline; thus, it is likely that low choline intake accentuated the methyl group deficiency caused by folate deficiency (Jacob et al. 1999) . One should also recognize that not all aspects of methyl group metabolism are impaired during folate deficiency. In a previous study of shortterm folate depletion coupled with low methionine and choline intakes in men, plasma homocysteine concentration increased, whereas methylation of a test dose of nicotinamide (as an indicator of methylation capacity) was unchanged (Jacob et al. 1995) .
In summary, the findings reported here illustrate clear kinetic differences between folate pools functioning directly in methyl group metabolism and those from which folate catabolites are primarily generated. From the point of view of the design of nutrition intervention studies regarding folate, this study adds to the growing body of evidence that most studies of practical duration do not achieve a steady state of folate status or metabolism. Hence, such intervention studies must be interpreted cautiously regarding effects of relatively short-term dietary treatments. However, these observations also indicate that clear changes in plasma folate concentration and aspects of methyl group metabolism occur well before complete attainment of steady state of all tissue folate pools.
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